1. Home
  2. SNGX vs HUBC Comparison

SNGX vs HUBC Comparison

Compare SNGX & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.39

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

HUBC

Hub Cyber Security Ltd.

HOLD

Current Price

$0.75

Market Cap

6.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
HUBC
Founded
1987
2017
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
6.6M
IPO Year
2006
2022

Fundamental Metrics

Financial Performance
Metric
SNGX
HUBC
Price
$0.39
$0.75
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
245.5K
309.5K
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
N/A
EPS
N/A
N/A
Revenue
$119,371.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.06
52 Week High
$6.23
$7.00

Technical Indicators

Market Signals
Indicator
SNGX
HUBC
Relative Strength Index (RSI) 46.90 34.62
Support Level $0.37 $0.11
Resistance Level $0.38 $1.16
Average True Range (ATR) 0.02 0.11
MACD 0.01 -0.03
Stochastic Oscillator 56.05 5.91

Price Performance

Historical Comparison
SNGX
HUBC

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in developing reliable quality assurance systems that support process and product enhancement and also operates in the industry of secured data fabric. The company serves various organizations and institutions operating in the security, electronics, aviation, telecommunications, and banking. The company has two operating segments: Product and Technology Segment and Professional Services Segment. The majority of revenue comes from the professional services segment, which provides data and cybersecurity and system security and reliability solutions and related services such as consulting, planning, integrating and ongoing servicing of cybersecurity, risk management, reliability and security projects and fully managed corporate cybersecurity services.

Share on Social Networks: